Health Canada approves radiopaque bead for HCC, CRC liver metastases

Canada, 25 August 2016

BTG International Canada Inc. announced it received approval for its drug-eluding device, the DC Bead LUMI, from Health Canada. The bead is the first commercially available product for patients with hepatocellular carcinoma and colorectal cancer metastasized to the liver.

Read More >

Data